Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Albrecht

Showing results (151-160 of 213) with videos related to

Pageof 22
Sort By:
Journal of Medical Virology|January 1, 1984
Immunogenicity of wild and attenuated varicella-zoster virus strains in rhesus monkeysY Asano, P Albrecht, D E Behr, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|July 1, 1995
[Dynamic function tests for detection of physiologic and pathophysiologic reactions in cutaneous microcirculation]H P Albrecht, D Hiller, M Mück-Weymann, et al.
Archiv Fur Die Gesamte Virusforschung|January 1, 1972
Foamy virus serotypes 1 and 2 in rhesus monkey tissuesT C O'Brien, P Albrecht, J E Hannah, et al.
Lancet (London, England)|October 15, 1983
Failure to isolate virus from CSF of schizophrenicsB Mered, P Albrecht, E F Torrey, et al.
The Journal of Infectious Diseases|July 1, 1992
Persistence of measles antibody after revaccinationL E Markowitz, P Albrecht, W A Orenstein, et al.
The Journal of Infectious Diseases|January 1, 1987
The plaque-neutralization test as a measure of prior exposure to measles virusW A Orenstein, P Albrecht, K L Herrmann, et al.
Microvascular Research|July 1, 1996
Respiratory-dependent laser-Doppler flux motion in different skin areas and its meaning to autonomic nervous control of the vessels of the skinM E Mück-Weymann, H P Albrecht, D Hager, et al.
Developments in Biological Standardization|January 1, 1986
Immunity against measles and rubella in Massachusetts schoolchildrenW A Orenstein, K Herrmann, P Albrecht, et al.
Scientific Reports|September 11, 2023
Real-world evidence of ocrelizumab-treated relapsing multiple sclerosis cohort shows changes in progression independent of relapse activity mirroring phase 3 trialsJ Ingwersen, L Masanneck, M Pawlitzki, et al.
Circulation|June 15, 1996
Power law behavior of RR-interval variability in healthy middle-aged persons, patients with recent acute myocardial infarction, and patients with heart transplantsJ T Bigger, R C Steinman, L M Rolnitzky, et al.
Pageof 22

Showing results (151-160 of 213) with videos related to

Sort By:
Pageof 22
Journal of Medical Virology|January 1, 1984
Immunogenicity of wild and attenuated varicella-zoster virus strains in rhesus monkeysY Asano, P Albrecht, D E Behr, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|July 1, 1995
[Dynamic function tests for detection of physiologic and pathophysiologic reactions in cutaneous microcirculation]H P Albrecht, D Hiller, M Mück-Weymann, et al.
Archiv Fur Die Gesamte Virusforschung|January 1, 1972
Foamy virus serotypes 1 and 2 in rhesus monkey tissuesT C O'Brien, P Albrecht, J E Hannah, et al.
Lancet (London, England)|October 15, 1983
Failure to isolate virus from CSF of schizophrenicsB Mered, P Albrecht, E F Torrey, et al.
The Journal of Infectious Diseases|July 1, 1992
Persistence of measles antibody after revaccinationL E Markowitz, P Albrecht, W A Orenstein, et al.
The Journal of Infectious Diseases|January 1, 1987
The plaque-neutralization test as a measure of prior exposure to measles virusW A Orenstein, P Albrecht, K L Herrmann, et al.
Microvascular Research|July 1, 1996
Respiratory-dependent laser-Doppler flux motion in different skin areas and its meaning to autonomic nervous control of the vessels of the skinM E Mück-Weymann, H P Albrecht, D Hager, et al.
Developments in Biological Standardization|January 1, 1986
Immunity against measles and rubella in Massachusetts schoolchildrenW A Orenstein, K Herrmann, P Albrecht, et al.
Scientific Reports|September 11, 2023
Real-world evidence of ocrelizumab-treated relapsing multiple sclerosis cohort shows changes in progression independent of relapse activity mirroring phase 3 trialsJ Ingwersen, L Masanneck, M Pawlitzki, et al.
Circulation|June 15, 1996
Power law behavior of RR-interval variability in healthy middle-aged persons, patients with recent acute myocardial infarction, and patients with heart transplantsJ T Bigger, R C Steinman, L M Rolnitzky, et al.
Pageof 22